Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 172

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Diabetes and Progression of Carotid Atherosclerosis: The Insulin Resistance Atherosclerosis Study

Open access
Wagenknecht, Lynne E., Zaccaro, Daniel, Espeland, Mark A., Karter, Andrew J., O’Leary, Daniel H., Haffner, Steven M. · 2003 · Arteriosclerosis, Thrombosis, and Vascular Biology

Abstract

Objective— We sought to determine the rate of progression of carotid atherosclerosis in persons with normal glucose tolerance, impaired glucose tolerance, and undiagnosed and diagnosed type 2 diabetes. Methods and Results— The Insulin Resistance Atherosclerosis Study (IRAS) is an observational cohort study in which 1192 men and women were examined at a 5-year interval. Participants of 3 ethnic groups (non-Hispanic white, African American, and Hispanic) were selected from the general population to represent a range of glucose tolerance. Baseline and follow-up ultrasound studies were obtained to estimate progression of common carotid artery (CCA) and internal carotid artery (ICA) intimal-medial thickness (IMT). Baseline glucose tolerance status was defined by an oral glucose tolerance test and World Health Organization criteria. In persons with normal glucose tolerance, progression of CCA IMT was 3.8 μm/y, and ICA IMT, 17.7 μm/y. In both CCA and ICA, progression of IMT, unadjusted for cardiovascular disease (CVD) risk factors, was approximately twice the rate in persons with diabetes than in those with normal or impaired glucose tolerance. Adjustment for CVD risk factors attenuated these differences somewhat in both sites of the carotid artery. Persons with undiagnosed diabetes had a greater ICA IMT progression rate than did persons with diagnosed diabetes (33.9 μm/y vs 26.6 μm/y, P =NS). Progression rates did not differ between persons with normal and impaired glucose tolerance. Conclusions— Progression of carotid atherosclerosis is accelerated in persons with diabetes. Progression of ICA IMT is most pronounced in persons with undiagnosed diabetes. Early identification of diabetes and CVD risk factor control might reduce its atherosclerotic complications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.atv.0000072273.67342.6d

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 172

Metadata

Authors
Wagenknecht, L. E., Zaccaro, D., Espeland, M. A., Karter, A. J., O’Leary, D. H., & Haffner, S. M.
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
2003-06
Volume
23
Issue
6
Pages
1035-1041
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W2116544253
Cited by
172
References
6
FWCI
5.95
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diabetes and Progression of Carotid Atherosclerosis: The Insulin Resistance Atherosclerosis Study. https://app.cochat.ai/papers/10.1161/01.atv.0000072273.67342.6d
The paper
Wagenknecht, L. E., Zaccaro, D., Espeland, M. A., Karter, A. J., O’Leary, D. H., & Haffner, S. M. (2003). Diabetes and Progression of Carotid Atherosclerosis: The Insulin Resistance Atherosclerosis Study. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/01.atv.0000072273.67342.6d

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.